Publication | Open Access
The <scp>GPR</scp>55 antagonist <scp>CID</scp>16020046 protects against intestinal inflammation
92
Citations
51
References
2015
Year
Pharmacological blockade of GPR55 reduces experimental intestinal inflammation by reducing leukocyte migration and activation, in particular that of macrophages. Therefore, CID16020046 represents a possible drug for the treatment of bowel inflammation.
| Year | Citations | |
|---|---|---|
Page 1
Page 1